---
schema_version: "secwatch.filing_event.v1"
accession: "0001274737-25-000061"
form_type: "8-K"
ticker: "XGN"
cik: "0001274737"
company_name: "EXAGEN INC."
filed_at: "2025-07-29T23:59:59+00:00"
generated_at: "2026-05-17T23:32:52.091676+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Exagen Q2 revenue $17.2M (+14% YoY); net loss widens to $4.4M; FY guidance $65-70M

## Summary
- Revenue $17.2M, 14% YoY growth; AVISE CTD test volume +7% YoY, +14% QoQ; gross margin 60.4%.
- Net loss $4.4M vs $3.0M in Q2 2024; operating loss $2.6M, roughly flat; adjusted EBITDA -$1.7M.
- Cash $30.0M after $20.2M public offering and new credit facility; ASP $428, up $27 YoY.
- FY 2025 revenue guidance $65M-$70M; expects positive adjusted EBITDA in Q4 at high end.
- Appointed Dr. Michael Mahler as CSO; added Chas McKhann to board of directors.

## SEC filing metadata
- accession: 0001274737-25-000061
- form_type: 8-K
- ticker: XGN
- cik: 0001274737
- company_name: EXAGEN INC.
- filed_at: 2025-07-29T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1274737/000127473725000061/0001274737-25-000061-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1274737/000127473725000061/exdx-20250729.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001274737-25-000061
- JSON: https://secwatch.observer/filing/0001274737-25-000061.json
- Plain text: https://secwatch.observer/filing/0001274737-25-000061.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.